It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Osteocytes, cells ensconced within mineralized bone matrix, are the primary skeletal mechanosensors. Osteocytes sense mechanical cues by changes in fluid flow shear stress (FFSS) across their dendritic projections. Loading-induced reductions of osteocytic Sclerostin (encoded by Sost) expression stimulates new bone formation. However, the molecular steps linking mechanotransduction and Sost suppression remain unknown. Here, we report that class IIa histone deacetylases (HDAC4 and HDAC5) are required for loading-induced Sost suppression and bone formation. FFSS signaling drives class IIa HDAC nuclear translocation through a signaling pathway involving direct HDAC5 tyrosine 642 phosphorylation by focal adhesion kinase (FAK), a HDAC5 post-translational modification that controls its subcellular localization. Osteocyte cell adhesion supports FAK tyrosine phosphorylation, and FFSS triggers FAK dephosphorylation. Pharmacologic FAK catalytic inhibition reduces Sost mRNA expression in vitro and in vivo. These studies demonstrate a role for HDAC5 as a transducer of matrix-derived cues to regulate cell type-specific gene expression.
Osteocytes are mechanoresponsive within skeletal tissue. Here, the authors show that class IIa histone deacetylases are phosphorylated by focal adhesion kinase, suggesting that HDAC5 may propagate mechanobiological cues to regulate cell type-specific gene expression.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA
2 Department of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA
3 University of Washington, Department of Orthopaedics and Sports Medicine, Seattle, USA (GRID:grid.34477.33) (ISNI:0000000122986657)
4 Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA (GRID:grid.34477.33); Center for Advanced Orthopaedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA (GRID:grid.34477.33)
5 Department of Molecular Biology and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, USA (GRID:grid.34477.33)
6 Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA (GRID:grid.34477.33)
7 Center for Immunology and Inflammatory Diseases, Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA (GRID:grid.34477.33)
8 Boston University, Translational Dental Medicine, Henry M. Goldman School of Dental Medicine, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558)
9 Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA (GRID:grid.189504.1); Center for Advanced Orthopaedic Studies, Department of Orthopedic Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA (GRID:grid.189504.1)
10 Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA (GRID:grid.34477.33); Broad Institute of Harvard and MIT, Cambridge, USA (GRID:grid.66859.34)